MARÍA GABRIELA
RODRÍGUEZ MACÍAS
Investigadora Predoctoral
Publicacions (34) Publicacions de MARÍA GABRIELA RODRÍGUEZ MACÍAS
2023
-
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901
-
Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab
Antimicrobial agents and chemotherapy, Vol. 67, Núm. 7, pp. e0026623
-
Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
Cancers, Vol. 15, Núm. 3
-
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
Cancers, Vol. 15, Núm. 12
2022
-
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
Cancers, Vol. 14, Núm. 9
-
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
International Journal of Hematology, Vol. 115, Núm. 1, pp. 61-68
-
Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin
Expert Review of Hematology, Vol. 15, Núm. 3, pp. 203-214
2021
-
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938
-
Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
Molecular Oncology, Vol. 15, Núm. 9, pp. 2273-2284
-
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
Leukemia, Vol. 35, Núm. 6, pp. 1571-1585
-
Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
Leukemia and Lymphoma, Vol. 62, Núm. 5, pp. 1178-1186
-
Next generation cytogenetics in myeloid hematological neoplasms: Detection of cnvs and translocations
Cancers, Vol. 13, Núm. 12
2020
-
A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis
Medical Mycology, Vol. 58, Núm. 3, pp. 300-309
-
COVID-19 coagulopathy: An in-depth analysis of the coagulation system
European Journal of Haematology, Vol. 105, Núm. 6, pp. 741-750
-
Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation
Haematologica
-
Plzf-rarα, npm1-rarα, and other acute promyelocytic leukemia variants: The pethema registry experience and systematic literature review
Cancers, Vol. 12, Núm. 5
-
Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports
Clinical Drug Investigation, Vol. 40, Núm. 3, pp. 227-235
2019
-
A case-control study of real-life experience with ceftolozane-tazobactam in patients with hematologic malignancy and pseudomonas aeruginosa infection
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 2
-
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
The Lancet Infectious Diseases, Vol. 19, Núm. 9, pp. 988-1000
-
Methotrexate-induced subacute neurotoxicity surrounding an ommaya reservoir in a patient with lymphoma
American Journal of Case Reports, Vol. 20, pp. 1002-1005